LFVN — Lifevantage Corp
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 849146 ·
Last close
$6.26
Market Cap
$78.42M
52W High
$11.62
52W Low
$3.81
ADV30
47,997
Next earnings
2026-11-03
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 42,377,000 | 33,043,000 | 1,667,000 | — | 62,111,000 | 14,920,000 | 28,522,000 |
| Mar 2026 | 43,716,000 | 34,544,000 | 1,678,000 | 1,362,000 | 62,127,000 | 12,483,000 | 28,788,000 |
| Dec 2025 | 48,931,000 | 36,209,000 | 487,000 | 276,000 | 61,169,000 | 10,181,000 | 28,182,000 |
| Sep 2025 | 47,561,000 | 37,816,000 | 2,268,000 | 2,155,000 | 61,579,000 | 13,091,000 | 28,422,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$6,508,000
Investing CF
$-6,476,000
Financing CF
$-9,876,000
CapEx
$-2,733,000
Dividends Paid
$-2,281,000
Buybacks
$-6,280,000
EPS Diluted TTM
$0.45
As of
2026-08-30
Balance + Analyst (yfinance extras)
Retained Earnings
$-103,656,000
Inventory
$18,382,000
Receivables
$4,620,000
ST Investments
—
EBIT TTM
$6,581,000
Pretax Income TTM
$6,766,000
Interest Exp TTM
—
Analysts
2
Yahoo Snapshot (yfinance, live)
Total Revenue
$182,586,000
EBITDA
$9,473,000
Free Cash Flow
$6,001,875
Enterprise Value
$72,241,736
Total Cash
$14,920,000
Total Debt
$9,868,000
Shares Out
12,527,348
Trailing EPS
$0.40
Book Value
$2.68
ROE
14.9%
ROA
6.2%
Div Yield
3.26%
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 182,586,000 | 6,100,000 | 5,072,000 | 62,111,000 | 28,522,000 | 33,589,000 | 10,241,000 |
| Jun 2025 | 228,530,000 | 12,199,000 | 9,805,000 | 71,958,000 | 37,317,000 | 34,641,000 | 11,878,000 |
| Jun 2024 | 200,164,000 | 4,332,000 | 2,937,000 | 60,299,000 | 34,308,000 | 25,991,000 | 12,197,000 |
| Jun 2023 | 213,398,000 | 4,259,000 | 2,540,000 | 66,123,000 | 31,474,000 | 34,649,000 | 6,828,000 |
| Jun 2022 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
$203,560,000
NetIncome TTM
$5,546,000
OpCashFlow TTM
$0
Assets (Latest)
$60,299,000
Forward EPS
$0.39
Max Pain — expiry 2026-12-18
max pain strike: $7.50 · spot: $6.26 · call oi: 727 · put oi: 758
Expected Move to 2026-12-18:
±$2.78
(44.41%) —
implied range
$3.48 –
$9.04
· ATM straddle on $7.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ZOMDF | Zomedica Corp. | $78.40M | $0.08 | — |
| INCR | Intercure Ltd. | $78.17M | $5.21 | — |
| OSTX | OS Therapies Inc | $77.70M | $1.66 | — |
| GANX | Gain Therapeutics, Inc. | $77.69M | $1.78 | — |
| IBIO | iBio, Inc. | $76.53M | $1.19 | — |
News headlines (Yahoo Finance, 1h cache)
LifeVantage Unveils Turnaround Plan to Rebuild Brand, Margins and Growth
2026-09-24 07:02 · Yahoo
LifeVantage to Participate in the WTR Virtual Insights Conference on Wednesday, September 23, 2026
2026-09-18 12:00 · Yahoo
LifeVantage (LFVN) Q4 2026 Earnings Call Transcript
2026-08-31 13:21 · Yahoo
LifeVantage Corporation Q4 2026 Earnings Call Summary
2026-08-28 12:30 · Yahoo
Lifevantage Corp (LFVN) (Q4 2026) Earnings Call Highlights: Revenue Declines 23% Amid Strategic ...
2026-08-28 05:01 · Yahoo
Lifevantage Q4 Earnings Call Highlights
2026-08-27 23:04 · Yahoo
LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2026
2026-08-27 20:05 · Yahoo
LifeVantage Declares Quarterly Dividend
2026-08-21 12:00 · Yahoo
LifeVantage to Announce Fourth Quarter and Full Fiscal Year 2026 Results on August 27, 2026
2026-08-13 20:30 · Yahoo
LifeVantage Corporation (NASDAQ:LFVN) Pays A US$0.05 Dividend In Just Three Days
2026-05-28 11:01 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.